Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Tresiba (Insulin degludec) (NN1250)
Also known as: Degludec
print preview
bookmark
share with colleague
General Information
Company
Novo Nordisk A/S
Description
Long-acting insulin analog
Molecular Target
Insulin receptor (INSR)
Mechanism of Action
Insulin receptor agonist
Latest Stage of Development
Marketed
Indication
Diabetes
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy